Eloxx Pharmaceuticals, Inc. (ELOX) Ownership
ELOX ownership summary
as of October 17, 2026- Institutions
- 73.8% of shares outstanding
- Insiders
- 19.06% of shares outstanding
- Shares outstanding
- 4.0M
- Float
- 931K shares available to trade
- Short interest
- 1.48% 54K shares short
- Days to cover
- 1.90 short interest up 18.2% vs prior month
- Institutions 73.76%
- Insiders 19.06%
- Other investors 7.17%
ELOX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | 23.28% | 800K | $10.4M | +800,000 (0.0%) | June 30, 2026 |
| 2 | EcoR1 Capital, LLC | 11.64% | 400K | $5.2M | +400,000 (0.0%) | June 30, 2026 |
| 3 | Siren, L.L.C. | 11.64% | 400K | $5.2M | +400,000 (0.0%) | June 30, 2026 |
| 4 | Samsara BioCapital, LLC | 11.64% | 400K | $5.2M | +400,000 (0.0%) | June 30, 2026 |
| 5 | Aberdeen Group PLC | 11.64% | 400K | $5.2M | +400,000 (0.0%) | June 30, 2026 |
| 6 | Stonepine Capital Management Llc | 11.56% | 397K | $5.2M | +397,160 (0.0%) | June 30, 2026 |
| 7 | Vanguard Capital Management, LLC | 2.29% | 79K | $1.0M | +78,680 (0.0%) | June 30, 2026 |
| 8 | Vanguard Fiduciary Trust Co | 0.31% | 11K | $138,144 | +10,602 (0.0%) | June 30, 2026 |
| 9 | SEVEN GRAND MANAGERS, LLC | 0.29% | 10K | $130,300 | +10,000 (0.0%) | June 30, 2026 |
| 10 | Morgan Stanley - Brokerage Accounts | 0.04% | 1,544 | $20,118 | +1,544 (0.0%) | June 30, 2026 |
| 11 | Vanguard Global Advisers, LLC | 0.02% | 718 | $9,356 | +718 (0.0%) | June 30, 2026 |
| 12 | UBS Group AG | 0.02% | 637 | $8,300 | +637 (0.0%) | June 30, 2026 |
| 13 | Wells Fargo & Co | <0.01% | 126 | $1,642 | +126 (0.0%) | June 30, 2026 |
| 14 | Royal Bank of Canada | <0.01% | 98 | $1,277 | +98 (0.0%) | June 30, 2026 |
| 15 | Pioneer Family Office, LLC | <0.01% | 96 | $1,251 | +96 (0.0%) | June 30, 2026 |
| 16 | Altshuler Shaham Ltd | <0.01% | 25 | $326 | +25 (0.0%) | June 30, 2026 |
| 17 | Barclays PLC | <0.01% | 12 | $156 | +12 (0.0%) | June 30, 2026 |
| 18 | OLD POINT TRUST & FINANCIAL SERVICES N A | <0.01% | 5 | $65 | +5 (0.0%) | June 30, 2026 |
| 19 | Citigroup Inc | <0.01% | 4 | $52 | +4 (0.0%) | June 30, 2026 |
| 20 | Activest Wealth Management | <0.01% | 4 | $52 | +4 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 20 holders added 2.9M shares and 0 cut 0.
ELOX top mutual fund and ETF holders
9 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | abrdn Healthcare Investors | 7.83% | 269K | $3.5M | — | August 31, 2026 |
| 2 | abrdn Life Sciences Investors | 3.81% | 131K | $1.7M | — | August 31, 2026 |
| 3 | Vanguard MStar Total Stk Mkt Idx Invest | 1.67% | 57K | $748,912 | — | August 31, 2026 |
| 4 | EQ/Morgan Stanley Small Cap Growth K | 1.16% | 40K | $521,552 | — | August 31, 2026 |
| 5 | Fidelity Nasdaq Composite Index | 0.07% | 2,294 | $29,891 | — | August 31, 2026 |
| 6 | Vanguard Balanced Index Inv | 0.03% | 1,036 | $13,499 | — | August 31, 2026 |
| 7 | Vanguard MStar Inst Ttl StkMktIdxInstlPl | 0.03% | 877 | $11,427 | — | August 31, 2026 |
| 8 | Vanguard U.S. Eq Idx £ Acc | 0.02% | 718 | $9,356 | — | August 31, 2026 |
| 9 | Counterpoint Global CIBC U.S. Sm CpGrETF | <0.01% | 155 | $2,020 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ELOX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ELOX
Institutional investors own 73.8% of Eloxx Pharmaceuticals's shares and insiders 19.06%. The largest holder is Nantahala Capital Management, LLC with 23.28% of the shares (800K), as of June 30, 2026. Among the top 20 institutions, 20 added shares and 0 reduced their stake in the latest filings. Short interest is 1.48% of the float, or 1.90 days of average trading volume. The share count rose 14,987.0% since 2015.
Related: ELOX analyst forecast, ELOX key metrics. See the ELOX stock overview for the latest quote and news.
ELOX ownership FAQ
Who owns the most Eloxx Pharmaceuticals stock?
The largest shareholders of Eloxx Pharmaceuticals are Nantahala Capital Management, LLC (23.28%), EcoR1 Capital, LLC (11.64%), Siren, L.L.C. (11.64%), Samsara BioCapital, LLC (11.64%), Aberdeen Group PLC (11.64%).
What percentage of Eloxx Pharmaceuticals is owned by institutions?
Institutions hold 73.8% of Eloxx Pharmaceuticals's shares outstanding; insiders hold 19.06%.
Which funds own Eloxx Pharmaceuticals?
The largest fund holders of Eloxx Pharmaceuticals are abrdn Healthcare Investors (7.83%), abrdn Life Sciences Investors (3.81%), Vanguard MStar Total Stk Mkt Idx Invest (1.67%), EQ/Morgan Stanley Small Cap Growth K (1.16%), Fidelity Nasdaq Composite Index (0.07%).
What is Eloxx Pharmaceuticals's short interest?
54K shares of Eloxx Pharmaceuticals were sold short, 1.48% of the float; at the average daily volume it would take 1.90 days to cover.
How many shares of Eloxx Pharmaceuticals are outstanding?
Eloxx Pharmaceuticals has 4.0M shares outstanding, of which 931K are in the public float.